nodes	percent_of_prediction	percent_of_DWPC	metapath
Niacin—SLCO2B1—Rifampicin—leprosy	0.747	1	CbGbCtD
Niacin—Application site reaction—Dapsone—leprosy	0.00888	0.0444	CcSEcCtD
Niacin—HCAR2—skin of body—leprosy	0.00792	0.151	CbGeAlD
Niacin—Arterial thrombosis—Thalidomide—leprosy	0.00791	0.0396	CcSEcCtD
Niacin—QPRT—nervous system—leprosy	0.00585	0.111	CbGeAlD
Niacin—NNMT—eye—leprosy	0.00512	0.0975	CbGeAlD
Niacin—Fungal skin infection—Thalidomide—leprosy	0.0051	0.0255	CcSEcCtD
Niacin—HCAR2—testis—leprosy	0.00499	0.095	CbGeAlD
Niacin—Ascites—Thalidomide—leprosy	0.00469	0.0235	CcSEcCtD
Niacin—Raised liver function tests—Thalidomide—leprosy	0.00462	0.0231	CcSEcCtD
Niacin—Hernia—Thalidomide—leprosy	0.00455	0.0227	CcSEcCtD
Niacin—Skin exfoliation—Dapsone—leprosy	0.00397	0.0199	CcSEcCtD
Niacin—Vesiculobullous rash—Thalidomide—leprosy	0.0038	0.019	CcSEcCtD
Niacin—Enlargement abdomen—Thalidomide—leprosy	0.00354	0.0177	CcSEcCtD
Niacin—SLC16A3—eye—leprosy	0.0035	0.0666	CbGeAlD
Niacin—NNMT—tendon—leprosy	0.00339	0.0645	CbGeAlD
Niacin—Myasthenia—Thalidomide—leprosy	0.00339	0.017	CcSEcCtD
Niacin—Hypothyroidism—Thalidomide—leprosy	0.00332	0.0166	CcSEcCtD
Niacin—Burning sensation—Thalidomide—leprosy	0.00307	0.0153	CcSEcCtD
Niacin—Lung disorder—Thalidomide—leprosy	0.00301	0.0151	CcSEcCtD
Niacin—Hepatomegaly—Thalidomide—leprosy	0.00301	0.0151	CcSEcCtD
Niacin—NNMT—testis—leprosy	0.00281	0.0534	CbGeAlD
Niacin—Cholestasis—Thalidomide—leprosy	0.00281	0.014	CcSEcCtD
Niacin—Amblyopia—Thalidomide—leprosy	0.00276	0.0138	CcSEcCtD
Niacin—NNMT—nervous system—leprosy	0.00276	0.0524	CbGeAlD
Niacin—Skin ulcer—Thalidomide—leprosy	0.00274	0.0137	CcSEcCtD
Niacin—Rash pustular—Thalidomide—leprosy	0.00267	0.0134	CcSEcCtD
Niacin—Muscular weakness—Dapsone—leprosy	0.00267	0.0133	CcSEcCtD
Niacin—Tingling sensation—Thalidomide—leprosy	0.00265	0.0133	CcSEcCtD
Niacin—Influenza—Dapsone—leprosy	0.00261	0.0131	CcSEcCtD
Niacin—Jaundice cholestatic—Thalidomide—leprosy	0.00243	0.0121	CcSEcCtD
Niacin—Skin discolouration—Thalidomide—leprosy	0.00236	0.0118	CcSEcCtD
Niacin—Bone disorder—Thalidomide—leprosy	0.00236	0.0118	CcSEcCtD
Niacin—Hyperbilirubinaemia—Thalidomide—leprosy	0.00234	0.0117	CcSEcCtD
Niacin—Hyperuricaemia—Thalidomide—leprosy	0.0023	0.0115	CcSEcCtD
Niacin—Blood uric acid increased—Thalidomide—leprosy	0.00217	0.0109	CcSEcCtD
Niacin—SLC16A1—eye—leprosy	0.00213	0.0404	CbGeAlD
Niacin—Eructation—Thalidomide—leprosy	0.00209	0.0105	CcSEcCtD
Niacin—Skin exfoliation—Thalidomide—leprosy	0.00203	0.0102	CcSEcCtD
Niacin—Cramps of lower extremities—Thalidomide—leprosy	0.00196	0.0098	CcSEcCtD
Niacin—Tinnitus—Dapsone—leprosy	0.00195	0.00975	CcSEcCtD
Niacin—Oesophagitis—Thalidomide—leprosy	0.00195	0.00974	CcSEcCtD
Niacin—Rash maculo-papular—Thalidomide—leprosy	0.00194	0.00969	CcSEcCtD
Niacin—SLC16A3—testis—leprosy	0.00192	0.0365	CbGeAlD
Niacin—SLC16A3—nervous system—leprosy	0.00188	0.0358	CbGeAlD
Niacin—Hypertonia—Thalidomide—leprosy	0.00187	0.00935	CcSEcCtD
Niacin—Erythema—Dapsone—leprosy	0.00182	0.00911	CcSEcCtD
Niacin—Diabetes mellitus—Thalidomide—leprosy	0.00178	0.0089	CcSEcCtD
Niacin—Eczema—Thalidomide—leprosy	0.00172	0.00861	CcSEcCtD
Niacin—Vision blurred—Dapsone—leprosy	0.00172	0.00858	CcSEcCtD
Niacin—Vertigo—Dapsone—leprosy	0.00164	0.00818	CcSEcCtD
Niacin—Atrial fibrillation—Thalidomide—leprosy	0.00163	0.00817	CcSEcCtD
Niacin—Dermatitis bullous—Thalidomide—leprosy	0.00162	0.0081	CcSEcCtD
Niacin—Arthritis—Thalidomide—leprosy	0.00159	0.00796	CcSEcCtD
Niacin—Cough—Dapsone—leprosy	0.00159	0.00795	CcSEcCtD
Niacin—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.00155	0.00774	CcSEcCtD
Niacin—Disturbance in sexual arousal—Thalidomide—leprosy	0.00153	0.00768	CcSEcCtD
Niacin—Migraine—Thalidomide—leprosy	0.00152	0.00762	CcSEcCtD
Niacin—Face oedema—Thalidomide—leprosy	0.00149	0.00747	CcSEcCtD
Niacin—Tachycardia—Dapsone—leprosy	0.00145	0.00725	CcSEcCtD
Niacin—Liver function test abnormal—Thalidomide—leprosy	0.00143	0.00715	CcSEcCtD
Niacin—Dry skin—Thalidomide—leprosy	0.00142	0.0071	CcSEcCtD
Niacin—Orthostatic hypotension—Thalidomide—leprosy	0.00141	0.00707	CcSEcCtD
Niacin—SLC16A1—tendon—leprosy	0.00141	0.0268	CbGeAlD
Niacin—Muscular weakness—Thalidomide—leprosy	0.00136	0.00683	CcSEcCtD
Niacin—Abdominal distension—Thalidomide—leprosy	0.00135	0.00674	CcSEcCtD
Niacin—Insomnia—Dapsone—leprosy	0.00134	0.00672	CcSEcCtD
Niacin—Influenza—Thalidomide—leprosy	0.00134	0.00669	CcSEcCtD
Niacin—Dysphagia—Thalidomide—leprosy	0.00134	0.00669	CcSEcCtD
Niacin—Angina pectoris—Thalidomide—leprosy	0.0013	0.00652	CcSEcCtD
Niacin—Bronchitis—Thalidomide—leprosy	0.00129	0.00643	CcSEcCtD
Niacin—Erectile dysfunction—Thalidomide—leprosy	0.00123	0.00616	CcSEcCtD
Niacin—Gastrointestinal pain—Dapsone—leprosy	0.00121	0.00608	CcSEcCtD
Niacin—SLCO2B1—tendon—leprosy	0.00121	0.023	CbGeAlD
Niacin—Body temperature increased—Dapsone—leprosy	0.00117	0.00588	CcSEcCtD
Niacin—Abdominal pain—Dapsone—leprosy	0.00117	0.00588	CcSEcCtD
Niacin—SLC16A1—testis—leprosy	0.00117	0.0222	CbGeAlD
Niacin—Stomatitis—Thalidomide—leprosy	0.00116	0.00581	CcSEcCtD
Niacin—SLC16A1—nervous system—leprosy	0.00114	0.0218	CbGeAlD
Niacin—Sweating—Thalidomide—leprosy	0.00114	0.00572	CcSEcCtD
Niacin—Rhinitis—Thalidomide—leprosy	0.00107	0.00537	CcSEcCtD
Niacin—Hepatitis—Thalidomide—leprosy	0.00107	0.00536	CcSEcCtD
Niacin—Hypoaesthesia—Thalidomide—leprosy	0.00106	0.00533	CcSEcCtD
Niacin—SLC22A5—skin of body—leprosy	0.00106	0.0201	CbGeAlD
Niacin—Oedema peripheral—Thalidomide—leprosy	0.00105	0.00528	CcSEcCtD
Niacin—Visual impairment—Thalidomide—leprosy	0.00103	0.00516	CcSEcCtD
Niacin—SLCO2B1—testis—leprosy	0.001	0.0191	CbGeAlD
Niacin—Eye disorder—Thalidomide—leprosy	0.001	0.005	CcSEcCtD
Niacin—Tinnitus—Thalidomide—leprosy	0.000998	0.00499	CcSEcCtD
Niacin—SLCO2B1—nervous system—leprosy	0.000984	0.0187	CbGeAlD
Niacin—Angiopathy—Thalidomide—leprosy	0.000971	0.00486	CcSEcCtD
Niacin—Chills—Thalidomide—leprosy	0.00096	0.0048	CcSEcCtD
Niacin—Arrhythmia—Thalidomide—leprosy	0.000956	0.00478	CcSEcCtD
Niacin—Alopecia—Thalidomide—leprosy	0.000946	0.00473	CcSEcCtD
Niacin—Vomiting—Dapsone—leprosy	0.000944	0.00473	CcSEcCtD
Niacin—Malnutrition—Thalidomide—leprosy	0.000932	0.00466	CcSEcCtD
Niacin—Headache—Dapsone—leprosy	0.000931	0.00466	CcSEcCtD
Niacin—Flatulence—Thalidomide—leprosy	0.000918	0.00459	CcSEcCtD
Niacin—Tension—Thalidomide—leprosy	0.000914	0.00457	CcSEcCtD
Niacin—Nervousness—Thalidomide—leprosy	0.000905	0.00453	CcSEcCtD
Niacin—Muscle spasms—Thalidomide—leprosy	0.000896	0.00448	CcSEcCtD
Niacin—Nausea—Dapsone—leprosy	0.000882	0.00441	CcSEcCtD
Niacin—Vision blurred—Thalidomide—leprosy	0.000878	0.00439	CcSEcCtD
Niacin—Angioedema—Thalidomide—leprosy	0.000851	0.00426	CcSEcCtD
Niacin—Vertigo—Thalidomide—leprosy	0.000837	0.00419	CcSEcCtD
Niacin—Syncope—Thalidomide—leprosy	0.000836	0.00418	CcSEcCtD
Niacin—Leukopenia—Thalidomide—leprosy	0.000834	0.00417	CcSEcCtD
Niacin—Palpitations—Thalidomide—leprosy	0.000823	0.00412	CcSEcCtD
Niacin—Loss of consciousness—Thalidomide—leprosy	0.000819	0.0041	CcSEcCtD
Niacin—Cough—Thalidomide—leprosy	0.000813	0.00407	CcSEcCtD
Niacin—SLC22A5—tendon—leprosy	0.000804	0.0153	CbGeAlD
Niacin—Myalgia—Thalidomide—leprosy	0.000793	0.00397	CcSEcCtD
Niacin—Arthralgia—Thalidomide—leprosy	0.000793	0.00397	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000788	0.00394	CcSEcCtD
Niacin—Dry mouth—Thalidomide—leprosy	0.000776	0.00388	CcSEcCtD
Niacin—Oedema—Thalidomide—leprosy	0.00076	0.0038	CcSEcCtD
Niacin—Shock—Thalidomide—leprosy	0.000748	0.00374	CcSEcCtD
Niacin—Tachycardia—Thalidomide—leprosy	0.000742	0.00371	CcSEcCtD
Niacin—Skin disorder—Thalidomide—leprosy	0.000739	0.0037	CcSEcCtD
Niacin—Hyperhidrosis—Thalidomide—leprosy	0.000735	0.00368	CcSEcCtD
Niacin—Anorexia—Thalidomide—leprosy	0.000725	0.00363	CcSEcCtD
Niacin—Hypotension—Thalidomide—leprosy	0.000711	0.00356	CcSEcCtD
Niacin—Musculoskeletal discomfort—Thalidomide—leprosy	0.000693	0.00347	CcSEcCtD
Niacin—Insomnia—Thalidomide—leprosy	0.000688	0.00344	CcSEcCtD
Niacin—Paraesthesia—Thalidomide—leprosy	0.000683	0.00342	CcSEcCtD
Niacin—Dyspnoea—Thalidomide—leprosy	0.000678	0.00339	CcSEcCtD
Niacin—Somnolence—Thalidomide—leprosy	0.000676	0.00338	CcSEcCtD
Niacin—Dyspepsia—Thalidomide—leprosy	0.000669	0.00335	CcSEcCtD
Niacin—SLC22A5—testis—leprosy	0.000666	0.0127	CbGeAlD
Niacin—Decreased appetite—Thalidomide—leprosy	0.000661	0.00331	CcSEcCtD
Niacin—Gastrointestinal disorder—Thalidomide—leprosy	0.000656	0.00328	CcSEcCtD
Niacin—Pain—Thalidomide—leprosy	0.00065	0.00325	CcSEcCtD
Niacin—Gastrointestinal pain—Thalidomide—leprosy	0.000622	0.00311	CcSEcCtD
Niacin—Urticaria—Thalidomide—leprosy	0.000604	0.00302	CcSEcCtD
Niacin—Abdominal pain—Thalidomide—leprosy	0.000601	0.00301	CcSEcCtD
Niacin—Body temperature increased—Thalidomide—leprosy	0.000601	0.00301	CcSEcCtD
Niacin—Hypersensitivity—Thalidomide—leprosy	0.00056	0.0028	CcSEcCtD
Niacin—Asthenia—Thalidomide—leprosy	0.000546	0.00273	CcSEcCtD
Niacin—Pruritus—Thalidomide—leprosy	0.000538	0.00269	CcSEcCtD
Niacin—Diarrhoea—Thalidomide—leprosy	0.00052	0.0026	CcSEcCtD
Niacin—Dizziness—Thalidomide—leprosy	0.000503	0.00252	CcSEcCtD
Niacin—Vomiting—Thalidomide—leprosy	0.000483	0.00242	CcSEcCtD
Niacin—Rash—Thalidomide—leprosy	0.000479	0.0024	CcSEcCtD
Niacin—Dermatitis—Thalidomide—leprosy	0.000479	0.0024	CcSEcCtD
Niacin—Headache—Thalidomide—leprosy	0.000476	0.00238	CcSEcCtD
Niacin—Nausea—Thalidomide—leprosy	0.000452	0.00226	CcSEcCtD
Niacin—CYP2D6—testis—leprosy	0.00043	0.00818	CbGeAlD
Niacin—CYP2D6—nervous system—leprosy	0.000422	0.00802	CbGeAlD
